Literature DB >> 21283319

Use of calcium ion entry blockers in family practice.

P H Tanser.   

Abstract

Verapamil, nifedipine, and diltiazem are drugs which decrease intracellular calcium in cardiac muscle, smooth muscle, and nodal cardiac cells. Unlike B-blockers, each drug acts at a different site on the cell membrane and has an important difference in overall action. Verapamil is used to treat angina, systemic hypertension, hypertrophic cardiomyopathy, and supraventricular and junctional tachyarrhythmias. Nifedipine is useful in angina, vasospastic disorders, and hypertension. A specific role for diltiazem is now being defined.

Entities:  

Year:  1983        PMID: 21283319      PMCID: PMC2153756     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

Review 1.  Management of arrhythmias with "calcium antagonists".

Authors:  D P Zipes; R F Gilmour
Journal:  Angiology       Date:  1982-08       Impact factor: 3.619

Review 2.  The hemodynamic effects of calcium channel blocking agents: a brief review.

Authors:  J Kieval; R J Myerburg
Journal:  Angiology       Date:  1982-08       Impact factor: 3.619

3.  Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.

Authors:  A Schwartz
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

Review 4.  Pharmacological basis for the therapeutic applications of slow-channel blocking drugs.

Authors:  B N Singh
Journal:  Angiology       Date:  1982-08       Impact factor: 3.619

5.  Calcium antagonists: an overview.

Authors:  T D Giles
Journal:  Angiology       Date:  1982-08       Impact factor: 3.619

Review 6.  Calcium antagonists in the treatment of individuals with ischemic heart disease.

Authors:  M D Winniford; J T Willerson; L D Hillis
Journal:  Angiology       Date:  1982-08       Impact factor: 3.619

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.